Edgewise Therapeutics, Inc. — Director's Dealing 2021

Dec 30, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Edgewise Therapeutics, Inc. (EWTX)
CIK: 0001710072
Period of Report: 2021-12-28

Reporting Person: MOORE JOHN R (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-12-28	Common Stock	M	5400.00	$0.71	Acquired	6962.00	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-12-28	Stock Option (Right to Buy)	$0.71	M	5400.00	Disposed	2030-09-01	Common Stock (5400.00)	Direct

Footnotes

F1: Includes 1,562 shares purchased on November 15, 2021 pursuant to the Edgewise Therapeutics, Inc. 2021 Employee Stock Purchase Plan.

F2: 1/4th of the shares subject to the option became vested and exercisable on September 1, 2021 and 1/48th of the shares subject to the option continue to vest each month, subject to the Reporting Person continuing as a service provider through each vest date.